Literature DB >> 18428143

Cervical and oral human papillomavirus types in HIV-1 positive and negative women with cervical disease in South Africa.

Dianne J Marais1, Jo-Ann S Passmore, Lynette Denny, Candice Sampson, Bruce R Allan, Anna-Lise Williamson.   

Abstract

This study tested cervical and oral human papillomavirus (HPV) infection in HIV-1 seropositive (HIV+) and seronegative (HIV-) women to determine any association between infections at both sites and the difference in prevalence of the HPV types infecting these women. Participants were 115 women referred to a colposcopy clinic after diagnosis of abnormal cervical cytology. The women showed low grade cervical intraepithelial neoplasia (CIN1) or high grade disease (CIN2/3) or no CIN based on colposcopy and histology. Typing of HPV in cervical and oral cells was by Roche linear array and included direct sequencing on selected oral samples. Cervical HPV prevalence was 86.5% and 97.1% in HIV- and HIV+ women respectively. With the exception of HPV-45, prominent in HIV+ women, the hierarchy of predominant types were similar in HIV- and HIV+ women. HPV-16 was most prevalent in both HIV+ (41.7%) and HIV- women (38.5%) with CIN2/3. Significantly more HIV+ women had multiple cervical (>1) infections than HIV- women (36.1% vs. 88.2%, P < 0.001) and more oral HPV infections (45.5% and 25% respectively; P = 0.04). The most prevalent oral HPV types were HPV-33, -11, and -72. The majority of women did not have concordant oral and cervical HPV types, reflecting possible independence of infection at the two sites. HIV immune suppression did not impact significantly on the predominant types of cervical HPV infection (except for HPV-45). HIV+ women had more multiple HPV infections and those with severe cervical disease a similar prevalence of HIV-16 but a lower HPV-18 prevalence than HIV- women.

Entities:  

Mesh:

Year:  2008        PMID: 18428143     DOI: 10.1002/jmv.21166

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  23 in total

1.  Prevalence of cervical and oral human papillomavirus infections among US women.

Authors:  Martin Steinau; Susan Hariri; Maura L Gillison; Tatevic R Broutian; Eileen F Dunne; Zhen-yue Tong; Lauri E Markowitz; Elizabeth R Unger
Journal:  J Infect Dis       Date:  2013-12-05       Impact factor: 5.226

2.  Oral HPV prevalence in women positive for cervical HPV infection and their sexual partners: a German screening study.

Authors:  Ralf B Uken; Oliver Brummer; Carolin von Schubert-Bayer; Thomas Brodegger; Ingo U Teudt
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-03-09       Impact factor: 2.503

Review 3.  Oral human papillomavirus infection and head and neck cancers in HIV-infected individuals.

Authors:  Daniel C Beachler; Gypsyamber DʼSouza
Journal:  Curr Opin Oncol       Date:  2013-09       Impact factor: 3.645

4.  MZC Gel Inhibits SHIV-RT and HSV-2 in Macaque Vaginal Mucosa and SHIV-RT in Rectal Mucosa.

Authors:  Giulia Calenda; Guillermo Villegas; Patrick Barnable; Claudia Litterst; Keith Levendosky; Agegnehu Gettie; Michael L Cooney; James Blanchard; José A Fernández-Romero; Thomas M Zydowsky; Natalia Teleshova
Journal:  J Acquir Immune Defic Syndr       Date:  2017-03-01       Impact factor: 3.731

Review 5.  Oral HPV complications in HIV-infected patients.

Authors:  Jennifer E Cameron; Michael E Hagensee
Journal:  Curr HIV/AIDS Rep       Date:  2008-08       Impact factor: 5.071

Review 6.  The role of sexual behavior in head and neck cancer: implications for prevention and therapy.

Authors:  Eleni Rettig; Ana Ponce Kiess; Carole Fakhry
Journal:  Expert Rev Anticancer Ther       Date:  2014-09-05       Impact factor: 4.512

7.  High-risk human papillomavirus is associated with HIV acquisition among South African female sex workers.

Authors:  Bertran Auvert; Dianne Marais; Pascale Lissouba; Kevin Zarca; Gita Ramjee; Anna-Lise Williamson
Journal:  Infect Dis Obstet Gynecol       Date:  2011-07-03

8.  Oral human papillomavirus in men having sex with men: risk-factors and sampling.

Authors:  Tim R H Read; Jane S Hocking; Lenka A Vodstrcil; Sepehr N Tabrizi; Michael J McCullough; Andrew E Grulich; Suzanne M Garland; Catriona S Bradshaw; Marcus Y Chen; Christopher K Fairley
Journal:  PLoS One       Date:  2012-11-16       Impact factor: 3.240

Review 9.  Association of genital human papillomavirus infection with HIV acquisition: a systematic review and meta-analysis.

Authors:  Pascale Lissouba; Philippe Van de Perre; Bertran Auvert
Journal:  Sex Transm Infect       Date:  2013-08       Impact factor: 3.519

10.  Prevalence of human papillomavirus infection in the oropharynx and urine among sexually active men: a comparative study of infection by papillomavirus and other organisms, including Neisseria gonorrhoeae, Chlamydia trachomatis, Mycoplasma spp., and Ureaplasma spp.

Authors:  Kazufumi Nakashima; Kazuyoshi Shigehara; Shohei Kawaguchi; Akira Wakatsuki; Yoshitomo Kobori; Kazuyoshi Nakashima; Yasunori Ishii; Masayoshi Shimamura; Toshiyuki Sasagawa; Yasuhide Kitagawa; Atsushi Mizokami; Mikio Namiki
Journal:  BMC Infect Dis       Date:  2014-01-27       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.